Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat in Tibetan patients with gout
ChiCTR1900021469Phase 4Recruiting
- Sponsor
- Hospital of Chengdu Office of the People's Government of Tibet Autonomous Region
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of febuxostat in gout and hyperuricemia, sponsored by Hospital of Chengdu Office of the People's Government of Tibet Autonomous Region. Primary endpoints: Blood uric acid and Tophus burden. Started Feb 2019; status: recruiting.
02
Drugs
febuxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on ChiCTR1900021469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021469.